A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Download All
In this comprehensive online program, experts discuss how to select optimal therapies for patients with B-cell lymphomas. Get up to date with expert commentaries, an on-demand webcast and slides from a dynamic CCO symposium at ASH 2021, downloadable resources on 10 key agent classes, and an audio podcast.
Julie M. Vose, MD, MBA
Program Director
Brad S. Kahl, MD
John P. Leonard, MD
Julie M. Vose, MD, MBA

Podcast

In this podcast episode, listen to Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, discuss current and emerging treatment approaches for patients with B-cell lymphomas from a recent satellite symposium at the annual Hematology meeting in 2021.

Brad S. Kahl, MD John P. Leonard, MD Julie M. Vose, MD, MBA Released: February 25, 2022

In these notes from a podcast, read expert insights from Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, on treatment options for patients with B-cell lymphomas from a recent symposium held during the annual Hematology meeting in 2021.

Julie M. Vose, MD, MBA
Program Director
Brad S. Kahl, MD John P. Leonard, MD
Released: February 25, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Atara Biotherapeutics, Inc.
Bayer HealthCare Pharmaceuticals Inc.
BeiGene, Ltd.
Epizyme
Genentech, a member of the Roche Group
Genmab US, Inc.
Incyte Corporation
Karyopharm Therapeutics
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings